cepharanthine has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hagiwara, S; Hasegawa, A; Koga, H; Kudo, K; Kusaka, J; Noguchi, T | 1 |
| Asanuma, M; Hirai, K; Kitayama, S; Miyazaki, I; Ohyama, K; Sasaki, A; Sogawa, C; Sogawa, N; Tsukamoto, G | 1 |
2 other study(ies) available for cepharanthine and Kidney Diseases
| Article | Year |
|---|---|
Cepharanthine improves renal ischemia-reperfusion injury in rats.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzylisoquinolines; Disease Models, Animal; Kidney; Kidney Diseases; Male; Malondialdehyde; Microscopy, Electron, Transmission; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury | 2011 |
Protective effect of cepharanthin on cisplatin-induced renal toxicity through metallothionein expression.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Cell Line; Chlorocebus aethiops; Cisplatin; COS Cells; Kidney; Kidney Diseases; Male; Metallothionein; Mice; Mice, Inbred C57BL; RNA, Messenger; Up-Regulation | 2013 |